Cleared Traditional

K924362 - VACUPLUS TUBES WITH LAVANDER STOPPERS

K924362 is an FDA 510(k) clearance for VACUPLUS TUBES WITH LAVANDER STOPPERS, manufactured by Starplex Scientific, Inc.. The device is a Class 2 Chemistry device with product code JKA cleared through the Traditional 510(k) pathway after a 185-day FDA review.

K924362 · Starplex Scientific, Inc. · Chemistry device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Mar 1993
Decision
185d
Days
Class 2
Risk

K924362 is an FDA 510(k) clearance for the VACUPLUS TUBES WITH LAVANDER STOPPERS. Classified as Tubes, Vials, Systems, Serum Separators, Blood Collection (product code JKA), Class II - Special Controls.

Submitted by Starplex Scientific, Inc. (Etobicoke, Ontario, CA). The FDA issued a Cleared decision on March 1, 1993 after a review of 185 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1675 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K924362

510(k) Number K924362 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 28, 1992
Decision Date March 01, 1993
Days to Decision 185 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
96d slower than avg
Panel avg: 89d · This submission: 185d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JKA Device Classification - Class 2, Special Controls

Product Code JKA Tubes, Vials, Systems, Serum Separators, Blood Collection
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1675
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JKA Tubes, Vials, Systems, Serum Separators, Blood Collection

All 239
Devices cleared under the same product code (JKA) and FDA review panel - the closest regulatory comparables to K924362.
MARKSMAN ARTERIAL BLOOD GAS SYRINGE
K931924 · Martech Medical Products, Inc. · Aug 1993
VACUTAINER BRAND LUER ADAPTER
K931367 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1993
VACUPLUS TUBES WITH GREEN STOPPERS
K924361 · Starplex Scientific, Inc. · Mar 1993
VACUPLUS TUBES WITH GREY STOPPERS
K924364 · Starplex Scientific, Inc. · Mar 1993
VACUPLUS(R) STAR-SEP(TM)
K924363 · Starplex Scientific, Inc. · Feb 1993
VACUPLUS TUBES WITH BRICK RED STOPPERS
K924365 · Starplex Scientific, Inc. · Dec 1992
K924362 · VACUPLUS TUBES WITH LAVANDER STOPPERS
Download PDF FDA Summary Starplex Scientific, …